Response to hepatitis A vaccine in HIV-positive patients

Journal of Viral Hepatitis

Volumn 13, Issue 2, 2006, Pages 81-86

  Weissman, S ^a,d   Feucht, C ^b   Moore, B A ^c  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Hepatitis A vaccine; Human immunodeficiency virus; Immune response

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ANTIBODY RESPONSE; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; DOSE RESPONSE; FEMALE; GENDER; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; VACCINATION; VIRUS LOAD;

EID: 33645104717     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00658.x     Document Type: Conference Paper

References (18)

1. Shapiro CN Coleman PJ McQuillan GM et al. 1992 Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA Vaccine 1992 10 Suppl. 1 S59
2. Hepatitis A among homosexual men-United States, Canada, and Australia MMWR 1992 41 155 163
3. Kaplan JE Masur H Holmes KK 2002 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus MMWR 2002 51 RR8
4. Vento S Garofano T Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C N Engl J Med 1998 338 286
5. Clemens R Safary A Hepburn A Roche C Standbury WJ Andre FE Clinical experience with an inactivated hepatitis A vaccine J Infec Dis 1995 171 Suppl. 1 S44 S49
6. Santagostino E Gringeri A Rocino A et al. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients Thrombosis and Haemostasis 1994 72 508
7. Neilsen GA Bodsworth NJ Watts N Response to hepatitis A vaccination in human immunodeficiency virus-infected and uninfected homosexual men J Infect Dis 1997 176 1064
8. Kemper CA Haubrich R Frank I et al. Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial J Infect Dis 2003 187 1327 1331
9. Keet IPM van Doornum G Safary A Coutinho RA Insufficient response to hepatitis B vaccination in HIV-positive homosexual men AIDS 1992 6 509 510
10. Opravil M Mattr FL Blaser J Luthy R Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients Clin Exp Immunol 1991 84 185 189
11. Kroon FP van Dissell JT de jong JC van Furth R Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4 lymphocytes AIDS 1994 8 469 476
12. Wallace MR Tasker SA Earhart KC Kuter BJ Chamberlin-Brandt CJ Hepatitis A Vaccination Response in HIV-infected and Uninfected Subjects 39th annual meeting of the Infectious Disease Society of America; San Francisco 2001 abstract 379
13. Tilzey AJ Palmer SJ Harrington C O'Doherty MJ Hepatitis A vaccine responses in HIV-positive persons with haemophilia Vaccine 1996 14 1039 1041
14. Lederman HM Williams PL Wu JW et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion J Infect Dis 2003 188 1794 1803
15. Robbins DJ Krater J Kiang W et al. Detection of total antibody against hepatitis A virus by an automated microparticle enzyme immunoassay J Virol Methods 1991 32 255 263
16. Andre F Damme PV Safary A Banatvala J Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use Expert Rev Vaccines 2002 1 9 23
17. Lisgaris MV Rodriguez B Yadavalli GK et al. AIDS-defining Illnesses (ADIs) Develop with Lower CD4 Counts and Higher Plasma HIV RNA Levels in HIV-infected Women than in Men 11th CROI, San Francisco 2004 abstract 951
18. Prins M Robertson JR Brettle RP et al. Do gender differences in CD4 cell counts matter? AIDS 1999 13 2361 2364